P050027S023

None

FDA Premarket Approval P050027 S023

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP050027S023
Classification NameNone
Applicant
PMAP050027
SupplementS023

Supplemental Filings

Supplement NumberDateSupplement Type
P050027Original Filing
S025 2020-06-29 30-day Notice
S024
S023
S022
S021 2020-05-08 30-day Notice
S020 2020-02-24 30-day Notice
S019 2019-06-25 30-day Notice
S018
S017 2019-03-25 30-day Notice
S016
S015
S014 2018-09-17 Real-time Process
S013 2018-07-20 Real-time Process
S012 2018-04-23 30-day Notice
S011 2017-08-03 Normal 180 Day Track
S010 2017-06-23 135 Review Track For 30-day Notice
S009 2017-06-23 135 Review Track For 30-day Notice
S008 2017-02-15 30-day Notice
S007 2014-08-12 30-day Notice
S006 2014-07-02 30-day Notice
S005 2013-03-18 Normal 180 Day Track No User Fee
S004 2012-08-21 Special (immediate Track)
S003 2012-05-29 Real-time Process
S002 2010-09-24 Real-time Process
S001 2010-06-11 Real-time Process

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.